secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2023-04-05T23:59:59+00:00
Accession:  0001193125-23-092414
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics adopts one-year poison pill after unsolicited bid, share accumulation
--------------------------------------------------------------------------------

- Rights plan effective immediately, expires April 5, 2024; dividend of one right per share on April 17, 2023.
- Trigger at 10% beneficial ownership (15% for passive institutional); exercise price $6.00 per right.
- Rights become exercisable if threshold crossed; holders (except triggering party) can buy shares at 2x market value.
- Board may redeem rights for $0.001 each before trigger; company retaining financial advisor for strategic alternatives.
- Plan adopted in response to unsolicited acquisition proposal and share accumulation by certain investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523092414/0001193125-23-092414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523092414/d487171d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-092414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer